Pages that link to "Q46233171"
Jump to navigation
Jump to search
The following pages link to Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation (Q46233171):
Displaying 2 items.
- The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles (Q69253630) (← links)
- Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation (Q72032707) (← links)